Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
Takes charge to lead business innovation, strategy, alliance & partnerships
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
The target demographic will be those between the ages of 30 and 65 years
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Subscribe To Our Newsletter & Stay Updated